WuXi AppTec Partners to Offer Services with UK's Orbit Discovery
publication date: Mar 10, 2022
WuXi AppTec, China's largest CRDMO, formed a partnership with Orbit Discovery, an Oxford, UK peptide discovery company. Following discovery, Orbit will offer clients WuXi AppTec’s downstream services. These include peptide optimization, peptide production and manufacturing, giving clients quick access to clinically relevant data and materials. In addition, Orbit will offer WuXi AppTec's expertise in cell line and assay development and biophysical analysis. Orbit's discovery operations are based on its novel bead and microfluidic technology platforms that improve functional screening throughput. More details....
Stock Symbols: (SHA: 603259; HK: 2359)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.